EGM and Myconate Update

Plant Health Care PLC
05 May 2006


Immediate release                                                   5 May 2006



                              Plant Health Care plc
                                        
                  ('PHC', the 'Company' or 'Plant Health Care')
                                        
                                  Result of EGM            
                      and Update of French Myconate Trials
                                        

The Board of Plant Health Care, a leading provider of natural products for
plants and soil, announces that at its Extraordinary General Meeting ('EGM')
held today, the special resolutions proposed to shareholders (as set out in its
notice to shareholders dated 10 April 2006) ('the Circular') were duly passed.

On 10 April 2006, the Company announced that it was to raise £6.5 million,
before expenses, by way of a Placing of 10,000,000 new ordinary shares of 1p
each ('Ordinary Shares') at a price of 65p per new Ordinary Share. These new
Ordinary Shares were placed by Evolution Securities Limited with institutional
investors. The Placing was conditional on, inter alia, Shareholder approval at
an EGM. In addition, the authorities necessary for the allotment of the New
Ordinary Shares pursuant to the Placing were to be sought at the EGM.

Following completion of the Placing, the issued share capital of the Company
will increase to 40,180,222 fully paid Ordinary Shares and the new Ordinary
Shares will represent 24.9 per cent. of the enlarged issued share capital.

Application has been made to the London Stock Exchange for the 10,000,000 new
Ordinary Shares to be admitted to AIM, which is expected to become effective at
8.00 a.m. on 9 May 2006.


French Myconate Trials
The Board is also pleased to update shareholders on the completion of its
Myconate trials in France. The results of these tests were of particular
significance as not only did the corn crops show a spectacular increase in
yield, but also because weather conditions were found to be less than ideal for
the growing of corn.

Corn farming generally suits high temperature levels with high levels of
rainfall. The three test areas in France, chosen specifically by the Group for
these trials, exhibited a warm climate but one with a lower than average
rainfall level. Irrigation controls in France are also strict, meaning the tests
were carried out in conditions classed as 'stressful' for the crops.

Yield improvement from the three sites ranged between 11.5% and 16%,
significantly exceeding the average for the complete test programme carried out
across the globe. This has subsequently led to an increase in interest for
Myconate and the Group is in continued discussions with a consortium of French
seed companies. The consortium has already installed trials throughout France
with the results expected by the end of 2006.



                                     -ends-


For enquiries:

Plant Health Care plc                             Tel: [phone]
John Brady, Chief Executive


Tavistock Communications                          Tel: [phone]
Jeremy Carey
Christian Taylor-Wilkinson


Evolution Securities                              Tel: [phone]
Tim Worlledge
Tim Redfern




                      This information is provided by RNS
            The company news service from the London Stock Exchange